Literature DB >> 25825780

Reply to Tzoulis et al.: Genetic and clinical heterogeneity of essential tremor.

Hilal Unal Gulsuner1, Suleyman Gulsuner2, Fatma Nazli Mercan3, Onur Emre Onat4, Tom Walsh2, Hashem Shahin5, Ming K Lee2, Okan Dogu6, Tulay Kansu7, Haluk Topaloglu8, Bulent Elibol7, Cenk Akbostanci3, Mary-Claire King9, Tayfun Ozcelik10, Ayse B Tekinay11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25825780      PMCID： PMC4426455          DOI： 10.1073/pnas.1503756112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Genetic heterogeneity in human disease.

Authors:  Jon McClellan; Mary-Claire King
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

2.  HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystonia.

Authors:  Charalampos Tzoulis; Tetyana Zayats; Per Morten Knappskog; Bernd Müller; Jan Petter Larsen; Ole-Bjørn Tysnes; Laurence A Bindoff; Stefan Johansson; Kristoffer Haugarvoll
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

Review 3.  Update on genetics of essential tremor.

Authors:  F J Jiménez-Jiménez; H Alonso-Navarro; E García-Martín; O Lorenzo-Betancor; P Pastor; J A G Agúndez
Journal:  Acta Neurol Scand       Date:  2013-05-18       Impact factor: 3.209

Review 4.  'Essential tremor' or 'the essential tremors': is this one disease or a family of diseases?

Authors:  Elan D Louis
Journal:  Neuroepidemiology       Date:  2013-12-03       Impact factor: 3.282

5.  Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease.

Authors:  Hilal Unal Gulsuner; Suleyman Gulsuner; Fatma Nazli Mercan; Onur Emre Onat; Tom Walsh; Hashem Shahin; Ming K Lee; Okan Dogu; Tulay Kansu; Haluk Topaloglu; Bulent Elibol; Cenk Akbostanci; Mary-Claire King; Tayfun Ozcelik; Ayse B Tekinay
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.